Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

RECRUITING
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Description

This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.